Jet-Vac Technologies Releases Line of Engineered Fume Scrubbing Systems
Jet-Vac’s systems work by pulling contaminated fumes and gases into the flow of a wash fluid, which mixes air, gas, and liquid streams to produce a cleaning solution.
Jet-Vac Technologies released a line of engineered fume scrubbing systems aimed at preventing environmental releases, certifying regulatory compliance, and protecting employee health and safety.
The systems work by pulling contaminated fumes and gases into the flow of a wash fluid, which mixes air, gas, and liquid streams to produce a cleaning solution, the company said in an April 5, 2021 press release. The mixture is then separated from the wash liquid in a separation tank and the wash liquid is recycled and reused.
The scrubbing systems, which work to remove and neutralize acid fumes, noxious laboratory gases, particulates, odors, dust, and condensable contaminants, are also effective for gas and condensable vapor removal, are not affected by corrosive fumes, require low maintenance, and are economical for labs and production facilities.
Source: Jet-Vac Technologies
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
